[Systematic Review of the efficacy, effectiveness, safety and cost of Preimplantational Genetic Screening]

López-Pedraza MJ, Hernández-Menéndez MT, Guerra-Rodríguez M, Blasco-Amaro JA
Record ID 32015000007
Spanish
Authors' recommendations: There is insufficient evidence in the studies and reports reviewed to support the routine use of screening with PGS to avoid the birth of newborn with aneuploidies in elderly women with recurrent miscarriages and/or failures in the FIV cycles. Economics studies are needed to assess the efficiency of this intervention beyond the analytical description of the cost of the procedure presented in this report.
Details
Project Status: Completed
Year Published: 2012
URL for published report: http://www.madrid.org/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-disposition&blobheadername2=cadena&blobheadervalue1=filename%3DRevisi%C3%B3n+sistem%C3%A1tica+sobre+eficacia+efectividad+y+costes+del+diagn%C3%B3stico+gen%C3%A9tico+preimplantacional.pdf&blobheadervalue2=language%3Des%26site%3DPortalSalud&blobkey=id&blobtable=MungoBlobs&blobwhere=1352812946981&ssbinary=true
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Spain
MeSH Terms
  • Cost-Benefit Analysis
  • Genetic Testing
Contact
Organisation Name: Unidad de Evaluacion de Tecnologias Sanitarias
Contact Address: Elena Andradas Aragones, Unidad de Evaluacion de Tecnologias Sanitarias, Agencia Lain Entralgo, C/ Gran Via, 27, 8a, ES-28013 Madrid, Spain. Tel: +34 91 3089418; Fax: +34 91 3089458;
Contact Name: elena.andradas@salud.madrid.org
Contact Email: elena.andradas@salud.madrid.org
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.